Medicare Advantage Accelerates Claims Approval for Exoskeleton Devices
Lifeward reports accelerated Medicare Advantage claims approvals for ReWalk 7 Exoskeleton, improving access and payment timelines in 2025.
Lifeward reports accelerated Medicare Advantage claims approvals for ReWalk 7 Exoskeleton, improving access and payment timelines in 2025.
UnitedHealth plans to have most Medicare Advantage enrollees in four-star plans by 2026, while AI infrastructure deals influence technology and semiconductor markets, impacting health insurers and chipmakers alike.
The August 2025 OIG report analyzes Medicare billing for remote patient monitoring services, highlighting fraud risks and compliance recommendations amid rising RPM usage.
Study reveals Medicare Advantage beneficiaries face longer hospital stays post-pandemic, driven by skilled nursing facility shortages and administrative barriers, impacting healthcare operations and costs.
New MedPAC analysis finds increased Medicare Advantage enrollment has no significant negative effect on hospital profit margins, challenging claims from hospital groups.
Kaiser Family Foundation projects an 18% median rise in ACA exchange premiums for 2026, driven by market consolidation and regulatory dynamics impacting affordability and competition.
UnitedHealth Group anticipates 78% of Medicare Advantage members will be enrolled in plans rated four stars or above in 2024, enhancing eligibility for Medicare bonus payments and supporting its health insurance segment.
UnitedHealth expects about 78% of its Medicare Advantage members to be enrolled in plans rated four stars or above in 2027, signaling strong quality performance under CMS metrics.
The Trump administration expands eligibility for affordable 'copper plans' on ObamaCare exchanges, aiming to reduce premiums and increase insurance coverage nationwide.
Specialty insurance firms H.W. Kaufman Group, CRC Group, and AM Specialty Insurance announce key leadership changes to enhance underwriting expertise, operations, and strategic growth in the U.S. and global markets.